Wildon Farwell, Chief Medical Officer at Dyne Therapeutics, Inc. (DYN), sold 14,882 shares at $13.33 ($198K) on 2023-03-14, disclosed to the SEC on 2023-03-15.
Open-market sale of $198k DYN by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.33 | 7,441 | $99K | 50.0% |
| 2 | $13.33 | 7,441 | $99K | 50.0% |
| Total | $13.33 avg | 14,882 | $198K | 100% |
| Filing → |
| DYN | SELL | 2024-05-17 | $122K | — | Filing → |
| DYN | SELL | 2024-03-12 | $67K | — | Filing → |
| DYN | SELL | 2024-03-11 | $472K | — | Filing → |